Industry Information

Update January 15, 2024

Pralsetinib

Pralsetinib cas number 2097132-94-8 ,also known as GAVRETO, is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. It is used to treat...

Update January 02, 2024

What is the Tapinarof?

Tapinarof CAS Number 79338-84-4,also known as benvitimod which is a nonsteroidal, topical treatment that belongs to the unique class of naturally derived aryl hydrocarbon receptor (AhR). It sold...

Update December 29, 2023

Tezacaftor and Ivacaftor

Tezacaftor CAS 1152311-62-0 is a drug used for the treatment of cystic fibrosis (CF) in people six years and older, who have a F508del mutation, the most common type of mutation in the CFTR gene. It...

Update December 29, 2023

What is a Drug of Alpelisib ?

Alpelisib cas 1217486-61-7is in a class of medications called kinase inhibitors. It works to treat cancer by blocking the signals that cause cancer cells to multiply, which helps to stop the spread...

Update December 28, 2023

Ubrogepant

Ubrogepant cas number is 1374248-77-7 which is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or...

Update December 27, 2023

New guide to add Ticagrelor to treat UA/NSTEMI

The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) jointly publish a new clinical guideline for the treatment of unstable angina/non-ST-elevation myocardial...

Update December 27, 2023

What is the drug Rotigotine used For?

Rotigotine cas 99755-59-6 transdermal patch is used to treat Parkinson disease. It is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Rotigotine...

Update December 27, 2023

What is a Eletriptan?

Eletriptan is a headache medicine that narrows blood vessels around the brain. Eletriptan also reduces substances in the body that can trigger headache pain, nausea, sensitivity to light and sound,...

Update December 27, 2023

Stronger pharmaceutical intermediates

“The prospects for the development of pharmaceutical intermediates in China are still promising.” This is the information that the reporter learned from the experts at the second seminar on...